ArticleScience translational medicine2019

Comment on "PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL human leukemia".

Danilo Perrotti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.